Abstract:A wide range of biomedical devices are being used to treat cardiovascular diseases, and thus they routinely come into contact with blood. Insufficient hemocompatibility has been found to impair the functionality and safety of these devices through the activation of blood coagulation and the immune system. Numerous attempts have been made to develop surface modification approaches of the cardiovascular devices to improve their hemocompatibility. However, there are still no ideal "blood-friendly" coating materials, which possess the desired hemocompatibility, tissue compatibility, and mechanical properties. As a novel multifunctional material, graphene has been proposed for a wide range of biomedical applications. The chemical inertness, atomic smoothness, and high durability make graphene an ideal candidate as a surface coating material for implantable devices. Here, we evaluated the hemocompatibility of a graphene film prepared on quartz glasses (Gra-glasses) from a direct chemical vapor deposition process. We found that the graphene coating, which is free of transfer-mediating polymer contamination, significantly suppressed platelet adhesion and activation, prolonged coagulation time, and reduced <i>ex vivo</i> thrombosis formation. We attribute the excellent antithrombogenic properties of the Gra-glasses to the low surface roughness, low surface energy (especially the low polar component of the surface energy), and the negative surface charge of the graphene film. Given these excellent hemocompatible properties, along with its chemical inertness, high durability, and molecular impermeability, a graphene film holds great promise as an antithrombogenic coating for next-generation cardiovascular devices.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19790?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19790</a>.Typical Raman spectra of graphene on Gra-glass1, Gra-glass2, Gra-glass3, and Gra-tube surfaces; typical SEM images of Gra-glass1, Gra-glass2, and Gra-glass3 surfaces; the weight of thrombus formed on Gra-tube and bare tube samples placed at different positions; the surface of various samples observed by atomic force microscopy or an optical profiler; the contact angle between different liquid and various sample surfaces; linear fitting according to the formula 5 for different samples; the surface energy of different liquids; and hemocompatibility of graphene and its analogues from the literature (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19790/suppl_file/am0c19790_si_001.pdf">PDF</a>)Bare glass tubes were completely blocked by the thrombus, whereas the Gra-glass tubes retained excellent patency after <i>ex vivo</i> thrombogenicity experiments for 60 min (Video S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19790/suppl_file/am0c19790_si_002.mp4">MP4</a>)This article has not yet been cited by other publications.

Ex vivo evaluation of blood coagulation on endothelial glycocalyx-inspired surfaces using thromboelastography

Impact of surface coating and systemic anticoagulants on hemostasis and inflammation in a human whole blood model

In vitro hemocompatibility screening of a slippery liquid impregnated surface coating for extracorporeal organ support applications

Development of substrate-independent heparin coating to mitigate surface-induced thrombogenesis: efficacy and mechanism

Multistage Anticoagulant Surfaces: A Synergistic Combination of Protein Resistance, Fibrinolysis, and Endothelialization

Mimicking the Endothelium: Dual Action Heparinized Nitric Oxide Releasing Surface

Enhanced Hemocompatibility of a Direct Chemical Vapor Deposition-Derived Graphene Film

Engineered endothelium-mimicking antithrombotic surfaces via combination of nitric oxide-generation with fibrinolysis strategies

Surface Engineering for Endothelium‐Mimicking Functions to Combat Infection and Thrombosis in Extracorporeal Life Support Technologies

Endothelium‐Mimicking Surface Combats Thrombosis and Biofouling via Synergistic Long‐ and Short‐Distance Defense Strategy

Reduced thrombogenicity of nitinol stents--in vitro evaluation of different surface modifications and coatings

Methacrylate polymer layers bearing poly(ethylene oxide) and phosphorylcholine side chains as non-fouling surfaces: in vitro interactions with plasma proteins and platelets.

Bioinspired zwitterionic microgel-based coating: Controllable microstructure, high stability, and anticoagulant properties

Surface modification of neurovascular stents: from bench to patient

Elucidation of Endothelial Cell Hemostatic Regulation with Integrin-Targeting Hydrogels

A thrombin-triggered self-regulating anticoagulant strategy combined with anti-inflammatory capacity for blood-contacting implants

Cell Surface Functionalization with Heparin‐Conjugated Lipid to Suppress Blood Activation

Surface-functionalized design of blood-contacting biomaterials for preventing coagulation and promoting hemostasis

Dual surface modification of polydimethylsiloxane (PDMS) with antithrombin-heparin complex (ATH) and tissue plasminogen activator (t-PA) for enhanced antithrombotic activity

Nitric Oxide-Generating Self-Assembling Peptide Hydrogel Coating for Enhancing Hemocompatibility of Blood-Contacting Devices